(0.10%) 5 251.75 points
(0.06%) 39 666 points
(0.19%) 18 289 points
(0.18%) $78.40
(0.98%) $2.27
(-1.17%) $2 347.30
(-0.49%) $28.37
(0.11%) $1 008.30
(-0.11%) $0.927
(0.22%) $10.86
(-0.02%) $0.798
(-1.39%) $91.38
@ $7.11
Issued: 14 Feb 2024 @ 09:30
Return: 22.93%
Previous signal: Feb 13 - 09:30
Previous signal:
Return: -1.32 %
Live Chart Being Loaded With Signals
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites...
Stats | |
---|---|
Today's Volume | 306 001 |
Average Volume | 723 391 |
Market Cap | 846.86M |
EPS | $0 ( 2024-03-28 ) |
Next earnings date | ( $-0.110 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.33 |
ATR14 | $0.00900 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-07 | Tanimoto Sarina | Sell | 50 000 | Common Stock |
2024-05-07 | Tanimoto Sarina | Sell | 50 000 | Common Stock |
2024-05-07 | Lowenthal Richard E | Sell | 50 000 | Common Stock |
2024-05-07 | Lowenthal Richard E | Sell | 50 000 | Common Stock |
2024-04-23 | Tanimoto Sarina | Buy | 48 260 | Common Stock |
INSIDER POWER |
---|
38.67 |
Last 100 transactions |
Buy: 12 886 525 | Sell: 6 242 291 |
Volume Correlation
ARS Pharmaceuticals, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ARS Pharmaceuticals, Inc. Correlation - Currency/Commodity
ARS Pharmaceuticals, Inc. Financials
Annual | 2023 |
Revenue: | $30 000.00 |
Gross Profit: | $-43 000.00 (-143.33 %) |
EPS: | $-0.570 |
FY | 2023 |
Revenue: | $30 000.00 |
Gross Profit: | $-43 000.00 (-143.33 %) |
EPS: | $-0.570 |
FY | 2022 |
Revenue: | $1.32M |
Gross Profit: | $-16.00M (-1 216.11 %) |
EPS: | $-0.850 |
FY | 2021 |
Revenue: | $5.51M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.216 |
Financial Reports:
No articles found.
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators